What\'s new in COPD?
Journal Title: Przewodnik Lekarza - Year 2006, Vol 84, Issue 2
Abstract
Results of clinical studies conducted in patients with chronic obstructive pulmonary disease (COPD) in recent years have pointed out at new perspectives in the management of COPD. They include both pharmacological and non-pharmacological methods. Progress in pharmacological therapy results mainly due to introduction of long acting anticholinergic compound and combined therapy with long acting β2-agonists and inhaled corticosteroids. Non-invasive positive pressure ventilation (NIPPV) appears to play a significant role in the treatment of severe COPD exacerbations. Also pulmonary rehabilitation has found very important position in the management of COPD patients. However, from patients’ perspective the most important benefit resulting from new therapies is an improvement in health related quality of live.
Authors and Affiliations
Paweł Śliwiński
Keywords
Related Articles
- EP ID EP101976
- DOI -
- Views 88
- Downloads 0
Angiotensin converting enzyme inhibitors or angiotensin in diabetic nephropathy
Diabetic nephropathy occurs is the single leading cause of end-stage renal disease. Intensive diabetes management has been shown in large prospective randomized studies to delay the onset of microalbuminuria and the prog...
Natural history and treatment of Type 2 diabetes mellitus
The pathogenesis of type 2 diabetes mellitus involves abnormalities in insulin action, insulin secretion and endogenous glucose output. However, the sequence of phenomena leading to the development and progression of abn...
Angiotensin II antagonists in heart failure - current recommendations
Current guidelines of European Society of Cardiology on treatment of heart failure with the use of angiotensin II receptor antagonists are presented in this article.
Evaluation of the efficacy and tolerance of Soyfem in women in the early menopausal period
Objective: The evaluation of efficacy and tolerance of using Soyfem in women in the early postmenopausal period treated with the drug for 12 months. Design: 71 women in the early postmenopausal period were randomized a...
What\'s new in COPD?
Results of clinical studies conducted in patients with chronic obstructive pulmonary disease (COPD) in recent years have pointed out at new perspectives in the management of COPD. They include both pharmacological and...